Synonyms
3:10,11-bis(methylenebis(oxy))-8-methoxy-16-methyl-(8-beta)-rheada; 8-beta-methoxy-16-methyl-2,3:10,11-bis(methylenebis(oxy))rheadan; rheadine; rhoeadin; RHOEADINE; 8β-Methoxy-16-methyl-2,3:10,11-bis[methylenebis(oxy)]rheadan; Brn 0098745; Rheadan, 8-methoxy-16
IUPAC Name
(1R,14R,24S)-24-methoxy-13-methyl-5,7,19,21,25-pentaoxa-13-azahexacyclo[12.11.0.02,10.04,8.015,23.018,22]pentacosa-2,4(8),9,15(23),16,18(22)-hexaene
Molecular Formula
C21H21O6N
Canonical SMILES
CN1CCC2=CC3=C(C=C2C4C1C5=C(C(O4)OC)C6=C(C=C5)OCO6)OCO3
InChI
InChI=1S/C21H21NO6/c1-22-6-5-11-7-15-16(26-9-25-15)8-13(11)19-18(22)12-3-4-14-20(27-10-24-14)17(12)21(23-2)28-19/h3-4,7-8,18-19,21H,5-6,9-10H2,1-2H3/t18-,19-,21+/m1/s1
InChIKey
XRBIHOLQAKITPP-SBHAEUEKSA-N
Boiling Point
489.3°C at 760 mmHg
Application
An isoquinoline alkaloid used in the therapeutic field particularly for the prevention and the treatment of pathologies implying a central and/or peripheral disorder.
Alpha
D23 +235° (c = 1.01 in chloroform); D22 +174° (c = 0.69 in pyridine)
Refractive Index
1.5614 (estimate)
Uses
An isoquinoline alkaloid used in the therapeutic field particularly for the prevention and the treatment of pathologies implying a central and/or peripheral disorder.
Water Solubility
832.6mg/L(25°C)